CrushSCI.com
Journal Selection & Manuscript Polishing Services
Acta Neuropathologica Communications journal cover Medicine
Back to journal directory

Review Cycle Records

Acta Neuropathologica Communications

Springer SCIE OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
109.5Average days
108Median days
71Fastest days
200Longest days
2902025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

200 days

Methylation profiling and alternative classification approaches in a glioma-enriched FFPE stereotaxic biopsy cohort

AuthorsKatharina Johanna Weber; Jürgen Hench; Markus Zumpt; Thomas Eska; Moritz Armbrust; Pia Susann Zeiner; Tabea Isabelle Hartung; Viktoria Ruf; Eike Steidl; Mareike Dettki; Tim Fenton; Joachim Peter Steinbach; Marcus Czabanka; David Capper; Stephan Frank; Karl-Heinz Plate; Marie-Thérèse Forster; Patrick Nikolaus Harter

Affiliations1. Goethe University Frankfurt, University Hospital, Neurological Institute (Edinger Institute), Frankfurt am Main, Germany; 2. German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Frankfurt, Heidelberg, Germany; 3. Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany; 4. Goethe University Frankfurt, University Hospital, University Cancer Center (UCT), Frankfurt am Main, Germany; 5. Division of Neuropathology, Institute of Pathology, Basel University Hospital, Basel, Switzerland; 6. Ludwig Maximilians University Munich, University Hospital, Center for Neuropathology and Prion Research, Faculty of Medicine, Munich, Germany; 7. German Cancer Consortium (DKTK), Partner Site Munich, A Partnership Between German CancerResearch Center (DKFZ) and University/University Hospital, Ludwig Maximilians University Munich, Munich, Germany; 8. Goethe University Frankfurt, University Hospital, Dr. Senckenberg Institute of Neurooncology, Frankfurt am Main, Germany; 9. Goethe University Frankfurt, University Hospital, Department of Neurology, Frankfurt am Main, Germany; 10. University Hospital Hamburg-Eppendorf, Hamburg, Germany; 11. Goethe University Frankfurt, University Hospital, Institute of Neuroradiology, Frankfurt am Main, Germany; 12. School of Cancer Sciences, University of Southampton, Southampton, UK; 13. Goethe University Frankfurt, University Hospital, Department of Neurosurgery, Frankfurt am Main, Germany; 14. Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Berlin, Germany; 15. German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany; 16. Bavarian Center for Cancer Research (BZKF), Partner Site Munich, Munich, Germany

Source PDF DOI Publisher page
106 days

A rare missense variant impacting NEK1 kinase function is associated with ALS

AuthorsDavid Brenner; Anna Ponomarenko; Iris Petrut; Sofia Beyrle; Matilde Contardo; Isabel Loss; Constantin Radke; Jonas Frank; Eleni Zimmer; Matthias Schlesner; Pascal Achenbach; Wendy Scheveneels; Amr Aly; Hülya Nazlican; Jasper Hesebeck-Brinkmann; Patrick Oeckl; Kathrin Müller; Reiner Siebert; Tobias Böckers; Kristel van Eijk; Jan Veldink; Alexander Kleger; Medhanie Mulaw; Peter M. Andersen; Karin Forsberg; Jochen H. Weishaupt; Seyed Babak Loghmani; Thorsten Grehl; Philip van Damme; Joachim Weis; Alberto Catanese

Affiliations1. Department of Neurology, University Hospital Ulm, Ulm, Germany; 2. Center for Rare Diseases (ZSE) Ulm, Ulm University Hospital Center for Rare Diseases, Ulm, Germany; 3. German Center for Neurodegenerative Diseases (DZNE), Ulm, Germany; 4. Institute of Anatomy and Cell Biology, Ulm University School of Medicine, Ulm, Germany; 5. Department of Neurosciences, Laboratory of Neurobiology and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, Leuven, Belgium; 6. VIB, Center for Brain & Disease Research, Leuven, Belgium; 7. Institute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany; 8. Biomedical Informatics, Data Mining and Data Analytics, University of Augsburg, Augsburg, Germany; 9. Institute of Molecular Oncology and Stem Cell Biology (IMOS), Ulm University Hospital, Ulm, Germany; 10. Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, USA; 11. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA; 12. Department of Neurology, Centre for ALS and Other Motor Neuron Disorders, Alfried Krupp Krankenhaus Rüttenscheid, Essen, Germany; 13. Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany; 14. Core Facility Organoids, Ulm University, Ulm, Germany; 15. Department of Neurology, Brain Centre Rudolf Magnus, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands; 16. Division of Interdisciplinary Pancreatology, Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany; 17. Unit for Single-Cell Genomics, Medical Faculty, Ulm University, Ulm, Germany; 18. Department of Clinical Sciences, Neurosciences, Umeå University, Umeå, Sweden; 19. Department of Neurology, University Hospitals Leuven, Leuven, Belgium; 20. Institute of Neuroanatomy, University Clinic RWTH Aachen, Aachen, Germany

Source PDF DOI Publisher page
74 days

Low-input CSF cfDNA shallow whole-genome sequencing for CNV-based diagnosis and monitoring of leptomeningeal metastasis in lung cancer

AuthorsXiudong Guan; Yubing Li; Zongkun Shi; Juan An; Yichun Hua; Xiaosheng Ding; Xixi Zheng; Weiran Xu; Dainan Zhang; Zhan Xue; Peng Kang; Dandan Cao; Xiaoyan Li; Wang Jia

Affiliations1. Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; 2. Beijing Neurosurgical Institute, Beijing, China; 3. China National Clinical Research Center for Neurologic Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; 4. Department of Medical Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; 5. Genetron Health (Beijing) Co., Ltd., Beijing, China

Source PDF DOI Publisher page
110 days

Intrathecal (G 4 C 2 ) 149 delivery in C9orf72 -deficient mice yields mild motor dysfunction and ALS/FTD pathological hallmarks

AuthorsKatelyn A. Russell; Amelia A. Shahrabi; Suleyman C. Akerman; Matthew D. Byrne; Jeffrey D. Rothstein; Davide Trotti; Brigid K. Jensen; Aaron R. Haeusler

Affiliations1. Department of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University, Philadelphia, USA; 2. Jefferson Weinberg ALS Center, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University, Philadelphia, USA; 3. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA; 4. Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, USA

Source PDF DOI Publisher page
131 days

Patient-derived glioblastoma cultures preserve respiration phenotypes during ex vivo maintenance and show sex-associated differences in migration

AuthorsVeronika Matschke; Philip Glover; Robert Lucaciu; David Pickmann; Martin Scholz; Carsten Theiss; Daniel Hoffmann; Johann Matschke

Affiliations1. Department of Cytology, Institute of Anatomy, Ruhr-University Bochum, Bochum, Germany; 2. International Graduate School of Neuroscience (IGSN), Ruhr-University Bochum, Bochum, Germany; 3. Department of Neurosurgery, Academic Teaching Hospital of University Duisburg-Essen, Duisburg, Germany; 4. Bioinformatics and Computational Biophysics, University of Duisburg-Essen, Essen, Germany; 5. Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany; 6. German Cancer Consortium (DKTK) Partner Site Essen a Partnership Between DKFZ and University Hospital, Essen, Germany

Source PDF DOI Publisher page
95 days

Enhancing heme synthesis attenuates pathological α-synuclein propagation in vivo

AuthorsMasami Masuda-Suzukake; Masato Hasegawa; Takashi Nonaka

Affiliations1. Dementia Research Project, Department of Clinical Medical Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.